On the issue of post COVID-19 condition in patients with rheumatic diseases
Actual problems of rheumatology include the possibility of developing a wide range of long-term consequences of COVID-19, so-called post-COVID syndrome (PCS). The results of our own research are presented, during which among 45 patients over 18 years with rheumatic diseases (RD) PCS was detected in...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2022-05-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3148 |
_version_ | 1797862603819581440 |
---|---|
author | M. F. Beketova V. V. Babak M. D. Suprun T. V. Beketova O. A. Georginova |
author_facet | M. F. Beketova V. V. Babak M. D. Suprun T. V. Beketova O. A. Georginova |
author_sort | M. F. Beketova |
collection | DOAJ |
description | Actual problems of rheumatology include the possibility of developing a wide range of long-term consequences of COVID-19, so-called post-COVID syndrome (PCS). The results of our own research are presented, during which among 45 patients over 18 years with rheumatic diseases (RD) PCS was detected in 20% cases: 6 of them had ANCAassociated vasculitis (AAV) and one each for rheumatoid arthritis, juvenile arthritis and osteoarthritis. In AAV cases PCS was more severe and varied than in other RD: lung lesions according to computed tomography (up to the damage 75% of the lung parenchyma), skin an d nervous (Guillain–Barré syndrome) lesions, myalgias, arthralgias were present. In most patients PCS ended in recovery, sudden death occurred only in the patient with AAV. The frequency of RD’s relapses in patients with PCS was 9%. Relapses were not noted in AAV, against the background of anti-B cell therapy with rituximab. Our own results and literature data indicate that patients with RD after COVID-19 need careful continuous monitoring to detect long-term complications of coronavirus infection and early diagnosis of relapses of the underlying disease. |
first_indexed | 2024-04-09T22:22:02Z |
format | Article |
id | doaj.art-bf65b8e9c6a641528421f07276d49156 |
institution | Directory Open Access Journal |
issn | 1995-4484 1995-4492 |
language | Russian |
last_indexed | 2024-04-09T22:22:02Z |
publishDate | 2022-05-01 |
publisher | IMA PRESS LLC |
record_format | Article |
series | Научно-практическая ревматология |
spelling | doaj.art-bf65b8e9c6a641528421f07276d491562023-03-22T13:45:57ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922022-05-0160216216410.47360/1995-4484-2022-162-1642792On the issue of post COVID-19 condition in patients with rheumatic diseasesM. F. Beketova0V. V. Babak1M. D. Suprun2T. V. Beketova3O. A. Georginova4Lomonosov Moscow State UniversityV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; Central Clinical Hospital of the Administrative Directorate of the President of the Russian FederationLomonosov Moscow State UniversityActual problems of rheumatology include the possibility of developing a wide range of long-term consequences of COVID-19, so-called post-COVID syndrome (PCS). The results of our own research are presented, during which among 45 patients over 18 years with rheumatic diseases (RD) PCS was detected in 20% cases: 6 of them had ANCAassociated vasculitis (AAV) and one each for rheumatoid arthritis, juvenile arthritis and osteoarthritis. In AAV cases PCS was more severe and varied than in other RD: lung lesions according to computed tomography (up to the damage 75% of the lung parenchyma), skin an d nervous (Guillain–Barré syndrome) lesions, myalgias, arthralgias were present. In most patients PCS ended in recovery, sudden death occurred only in the patient with AAV. The frequency of RD’s relapses in patients with PCS was 9%. Relapses were not noted in AAV, against the background of anti-B cell therapy with rituximab. Our own results and literature data indicate that patients with RD after COVID-19 need careful continuous monitoring to detect long-term complications of coronavirus infection and early diagnosis of relapses of the underlying disease.https://rsp.mediar-press.net/rsp/article/view/3148post-covid syndromelong-covidcovid-19coronavirus disease 2019rheumatic diseasesanca-associated vasculitis |
spellingShingle | M. F. Beketova V. V. Babak M. D. Suprun T. V. Beketova O. A. Georginova On the issue of post COVID-19 condition in patients with rheumatic diseases Научно-практическая ревматология post-covid syndrome long-covid covid-19 coronavirus disease 2019 rheumatic diseases anca-associated vasculitis |
title | On the issue of post COVID-19 condition in patients with rheumatic diseases |
title_full | On the issue of post COVID-19 condition in patients with rheumatic diseases |
title_fullStr | On the issue of post COVID-19 condition in patients with rheumatic diseases |
title_full_unstemmed | On the issue of post COVID-19 condition in patients with rheumatic diseases |
title_short | On the issue of post COVID-19 condition in patients with rheumatic diseases |
title_sort | on the issue of post covid 19 condition in patients with rheumatic diseases |
topic | post-covid syndrome long-covid covid-19 coronavirus disease 2019 rheumatic diseases anca-associated vasculitis |
url | https://rsp.mediar-press.net/rsp/article/view/3148 |
work_keys_str_mv | AT mfbeketova ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases AT vvbabak ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases AT mdsuprun ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases AT tvbeketova ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases AT oageorginova ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases |